» Articles » PMID: 24876839

Primary Thyroid Disorders in Patients with Endogenous Hypercortisolism: an Observational Study

Overview
Publisher Wiley
Specialty Endocrinology
Date 2014 May 31
PMID 24876839
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Cushing's syndrome (CS) may alter the performance of the hypothalamic-hypophyseal-thyroid axis. We searched for a relationship between hypercortisolism and primary thyroid disorders. The medical records of 40 patients with CS were retrospectively examined. Thyroid ultrasonography (USG), basal thyroid function test results (TFT), and antithyroglobulin and antithyroperoxidase antibodies were analyzed. In 80 control subjects, matched by age and gender with CS patients, thyroid USG, TFTs, and autoantibody panel were obtained. Among the CS patients, 17 had nodular goiter, versus 24 controls (42.5% versus 30%, P > 0.05). Among the twenty-five patients with an available TFT and autoantibody panel-before and after surgical curative treatment-autoantibody positivity was detected in 2 (8%) patients before and 3 (12%) after surgery (P = 0.48). Regarding TFT results, 1 (2.5%) patient had subclinical hyperthyroidism and 1 (2.5%) had subclinical hypothyroidism, whereas 1 (2.5%) control had hyperthyroidism. In total, 21 (52.5%) patients and 32 (40%) controls had ≥1 of the features of thyroid disorder, including goiter, positive thyroid autoantibody, and thyroid function abnormality; the difference was not significant (P > 0.05). The prevalence of primary thyroid disorders is not significantly increased in patients with CS.

Citing Articles

Thyroid function spectrum in Cushing's syndrome.

Yu P, Yuan H, Chen H, Li X BMC Endocr Disord. 2024; 24(1):80.

PMID: 38840128 PMC: 11155018. DOI: 10.1186/s12902-024-01614-4.


Management of thyrotoxicosis occurring after surgery for Cushing's disease: a case series.

Jiang S, Yang C, Feng M, Yao Y, Deng K, Xing B Gland Surg. 2021; 10(5):1627-1637.

PMID: 34164307 PMC: 8184375. DOI: 10.21037/gs-21-49.

References
1.
da Mota F, Murray C, Ezzat S . Overt immune dysfunction after Cushing's syndrome remission: a consecutive case series and review of the literature. J Clin Endocrinol Metab. 2011; 96(10):E1670-4. DOI: 10.1210/jc.2011-1317. View

2.
Raccah D, Zeitoun C, Lafforgue P, Lassmann-Vague V, Mallet B, Vialettes B . [Inflammatory rheumatism flare-up after surgical treatment of Cushing's disease: two cases]. Rev Med Interne. 1992; 13(4):302-4. DOI: 10.1016/s0248-8663(05)80307-8. View

3.
Sayki Arslan M, Sahin M, Topaloglu O, Tutal E, Karakose M, Gungunes A . Hyperprolactinaemia associated with increased thyroid volume and autoimmune thyroiditis in patients with prolactinoma. Clin Endocrinol (Oxf). 2013; 79(6):882-6. DOI: 10.1111/cen.12217. View

4.
Rho M, Kim D, Hong H, Park Y, Kwon M, Jung S . Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results. Endocrine. 2012; 42(3):647-52. DOI: 10.1007/s12020-012-9695-y. View

5.
Nishiyama S, Takada K, Tada H, Takano T, Amino N . Effect of interleukin-6 on cell proliferation of FRTL-5 cells. Biochem Biophys Res Commun. 1993; 192(1):319-23. DOI: 10.1006/bbrc.1993.1416. View